« Previous Next » Journal of Cardiovascular Computed Tomography
Volume 4, Issue 1 , Pages 62-65 , January 2010

Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy

Received 22 June 2009 ,Accepted 14 October 2009.

References

Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775–785
- MEDLINE
- CrossRef
Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881–1891
Autore C, Bernabo P, Stella C, Bruzzi P, Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol. 2005;45:1076–1080
Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211–214
- Abstract
- CrossRef
Seggewiss H, Rigopoulos A, Welge D, Ziemssen P, Faber L. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol. 2007;96:856–863
- CrossRef
Okayama S, Uemura S, Horii M, Kawata H, Saito Y. Continuing improvement of cardiac sympathetic activity on I-123 MIBG scintigraphy in a patient with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation. J Nucl Cardiol. 2008;15:e31–e34
- CrossRef
Pichard AD, Meller J, Teichholz LE, Lipnik S, Gorlin R, Herman MV. Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis. Am J Cardiol. 1977;40:310–314
van Dockum WG, ten Cate FJ, ten Berg JM, Beek AM, Twisk JW, Vos J, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol. 2004;43:27–34